Crossmark

Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery

Published Online: 2021-07-07

Authors

Yang, Andrew

Nguyen, Melinda

Ju, Irene

Brancatisano, Anthony

Ryan, Brendan

van der Poorten, David
License Information

Text and Data Mining valid from 2021-07-07

Version of Record valid from 2021-07-07
More Information

Article History

Received: 1 March 2021

Accepted: 23 June 2021

First Online: 7 July 2021

Competing interests

: The authors declare no competing interests.

Document is current